Merus Labs International Inc.
Merus Labs International Inc., commonly referred to as Merus Labs, is a prominent pharmaceutical company headquartered in Canada. Founded in 2014, the company has established a strong presence in the specialty pharmaceuticals sector, focusing on the development and commercialisation of innovative therapies. With operations primarily in North America and Europe, Merus Labs is dedicated to providing high-quality products that address unmet medical needs. Their core offerings include a range of prescription medications, particularly in the areas of dermatology and infectious diseases, distinguished by their unique formulations and delivery methods. Merus Labs has achieved significant milestones, including strategic partnerships and a robust portfolio of proprietary products, positioning itself as a key player in the pharmaceutical industry. The company’s commitment to improving patient outcomes underscores its reputation for excellence and innovation in healthcare.
DitchCarbon Score
How does Merus Labs International Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Merus Labs International Inc.'s score of 23 is higher than 91% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Merus Labs International Inc.'s reported carbon emissions
In 2023, Merus Labs International Inc. reported carbon emissions totalling approximately 33,051,085 kg CO2e, with no emissions recorded under Scope 1 and Scope 2 emissions amounting to about 30,928 kg CO2e. This pattern of emissions has remained consistent since 2021, indicating a stable operational footprint in terms of direct and indirect emissions. The company has not established specific reduction targets or initiatives, nor does it participate in the Science Based Targets initiative (SBTi). This lack of formal commitments suggests that while Merus Labs is aware of its carbon footprint, it has yet to implement a structured approach to reducing its emissions. Overall, Merus Labs operates with a significant reliance on Scope 3 emissions, which dominate its total emissions profile. As the company continues to navigate its climate commitments, further transparency and strategic planning may be necessary to align with industry standards for sustainability and emissions reduction.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2021 | 2022 | 2023 | |
|---|---|---|---|
| Scope 1 | - | - | - |
| Scope 2 | 30,928 | 00,000 | 00,000 |
| Scope 3 | 33,051,085 | 00,000,000 | 00,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Merus Labs International Inc. is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
